AIC
HRMY icon

Aurora Investment Counsel’s Harmony Biosciences HRMY Stock Holding History

Aurora Investment Counsel’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
65,148
+2,365
+4% +$74.6K 1.22% 22
2026
Q1 		$1.76M Sell
62,783
-3,302
-5% -$108K 0.98% 50
2025
Q4 		$2.47M Buy
66,085
+2,514
+4% +$82.7K 1.3% 26
2025
Q3 		$1.75M Buy
63,571
+693
+1% +$23.9K 0.92% 58
2025
Q2 		$1.99M Buy
62,878
+1,211
+2% +$39K 1.05% 42
2025
Q1 		$2.05M Buy
61,667
+374
+0.6% +$13.4K 1.13% 36
2024
Q4 		$2.11M Buy
+61,293
New +$2.11M 1.16% 31

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aurora Investment Counsel's HRMY Position: Q2 2026 in Review

Aurora Investment Counsel increased its Harmony Biosciences (HRMY) stake by 3.8% in Q2 2026, buying an estimated $74.6K and bringing the position to 65,148 shares worth $2.37M. The position accounts for 1.22% of the portfolio, ranked #22.

Aurora Investment Counsel first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.47M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Aurora Investment Counsel held 65,148 shares of Harmony Biosciences worth $2.37M as of Q2 2026.
  • Aurora Investment Counsel bought 2,365 Harmony Biosciences shares in Q2 2026, an estimated $74.6K.
  • Harmony Biosciences made up 1.22% of Aurora Investment Counsel's portfolio in Q2 2026, its #22 holding.
  • Aurora Investment Counsel first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Aurora Investment Counsel's Harmony Biosciences position peaked at $2.47M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.